Dhanvantri Jeevan Rekha Ltd

Dhanvantri Jeevan Rekha Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.

Dhanvantri Jeev., a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts.

Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust demand and the possibility of a multi-day circuit scenario, underscoring heightened investor enthusiasm in the healthcare services sector.

Dhanvantri Jeevan Rekha Ltd, a key player in the healthcare services sector, has attracted extraordinary buying interest, resulting in an upper circuit situation with only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting robust demand and investor enthusiasm despite mixed performance metrics over various time frames.

Dhanvantri Jeevan Rekha Ltd has captured market attention with extraordinary buying momentum, registering a 4.99% gain today and hitting an upper circuit with exclusively buy orders in the queue. This rare scenario signals robust investor enthusiasm and the potential for a sustained multi-day circuit, setting the healthcare services stock apart from broader market trends.

Dhanvantri Jeevan Rekha Ltd, a key player in the Healthcare Services sector, has attracted remarkable buying interest today, with the stock hitting an upper circuit and registering exclusively buy orders in the queue. This unusual market behaviour signals a potential multi-day circuit scenario, reflecting strong investor enthusiasm despite recent mixed performance trends.

Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest on 27 Nov 2025, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a strong demand surge, potentially extending the circuit scenario over multiple trading sessions as sellers remain absent.

Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand in the healthcare services sector despite recent price fluctuations.

Dhanvantri Jeevan Rekha Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals robust demand and the potential for a multi-day circuit scenario, underscoring the stock’s prominence within the healthcare services sector.

Dhanvantri Jeevan Rekha Ltd has encountered severe selling pressure, with the stock hitting the lower circuit and registering only sell orders in the queue. This development signals distress selling and a lack of buyer interest, marking a significant moment for the healthcare services company amid volatile market conditions.

Dhanvantri Jeevan Rekha Ltd has captured market attention with extraordinary buying momentum, registering a 4.99% gain today while trading exclusively at the upper circuit price with no sellers in queue. This rare scenario signals a potential multi-day circuit lock, reflecting robust investor enthusiasm in the healthcare services sector amid broader market fluctuations.

Dhanvantri Jeevan Rekha Ltd has witnessed extraordinary buying momentum today, hitting the upper circuit with no sellers in the queue. This rare market phenomenon highlights intense demand for the healthcare services stock, suggesting a potential multi-day circuit scenario as investors continue to show strong conviction.

Dhanvantri Jeevan Rekha Ltd., a micro-cap healthcare services provider based in Meerut, reported a concerning Q2 FY26 performance marked by a net loss of ₹0.14 crores, a sharp reversal from the ₹0.06 crores profit posted in Q1 FY26. The company, with a market capitalisation of ₹10.00 crores and trading at ₹25.25, witnessed its operating profit margin slip into negative territory at -1.20%, raising serious questions about operational efficiency and cost management at the 30-year-old multi-speciality hospital.

Dhanvantri Jeevan Rekha Ltd is experiencing notable selling pressure, with recent trading sessions marked by consecutive losses. Despite outperforming the Sensex over longer periods, the stock has faced challenges recently, exhibiting mixed performance metrics and potential volatility, as indicated by its moving averages.

Dhanvantri Jeevan Rekha, a microcap in healthcare services, has adjusted its valuation, currently priced at 25.25. Over the past year, it achieved a 23.17% stock return, outperforming the Sensex. Key metrics include a PE ratio of 103.48 and a ROCE of -2.81%, indicating financial challenges compared to industry peers.

Dhanvantri Jeevan Rekha Ltd, a microcap in healthcare services, is experiencing notable buying interest despite recent trading challenges. While the stock has faced short-term declines, it has shown resilience over longer periods, significantly outperforming the Sensex in both three-month and annual returns. Its trading patterns remain mixed amid volatility.

Dhanvantri Jeevan Rekha Ltd, a microcap in healthcare services, is experiencing notable buying activity amid a flat stock performance today. Despite a recent decline over the past week, the stock has shown resilience with a significant gain over the last three months, outperforming the broader market.